Cargando…

Commentary: Cost-Effectiveness of Left Ventricular Assist Devices as Destination Therapy in the United Kingdom

Detalles Bibliográficos
Autores principales:	Faldu, Priyansh, Sharma, Kamal, Sharma, Shaival, Ramani, Smeet, Dadhania, Nain, Konat, Ashwati
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312126/ https://www.ncbi.nlm.nih.gov/pubmed/35898270 http://dx.doi.org/10.3389/fcvm.2022.916588

Ejemplares similares

Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
por: Shah, Aditya, et al.
Publicado: (2022)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
por: Rawal, Shalin, et al.
Publicado: (2022)

Repostioning of Telemedicine in Cardiovascular World Post-COVID-19 Pandemic
por: Sharma, Kamal, et al.
Publicado: (2022)

Pathophysiology and management of valvular disease in patients with destination left ventricular assist devices
por: Dimarakis, Ioannis, et al.
Publicado: (2022)

Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom
por: Schueler, Stephan, et al.
Publicado: (2021)

Sex-Specific Outcomes in Patients Receiving Continuous-Flow Left Ventricular Devices as a Bridge to Transplantation or Destination Therapy
por: Tsiouris, Athanasios, et al.
Publicado: (2014)

Impact of atmospheric variables on incidence of acute coronary syndrome amongst Gujarati Asian Indians – IOAPIC study
por: Konat, Ashwati, et al.
Publicado: (2023)

Ethical challenges with the left ventricular assist device as a destination therapy
por: Rizzieri, Aaron G, et al.
Publicado: (2008)

Left ventricular assist devices as destination therapy in stage D heart failure
por: Asleh, Rabea, et al.
Publicado: (2019)

Left ventricular assist device bioinformatics identify possible hubgenes and regulatory networks involved in the myocardium of patients with left ventricular assist device
por: Ajmal, Maryam, et al.
Publicado: (2022)

A Comprehensive Analysis of Myocarditis in Formerly Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization)
por: Sharma, Kamal, et al.
Publicado: (2022)

Aortic valve disorders and left ventricular assist devices
por: Acharya, Deepak, et al.
Publicado: (2023)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Sex Differences in Recovery and Device Replacement After Left Ventricular Assist Device Implantation as Destination Therapy
por: Maukel, Lisa‐Marie, et al.
Publicado: (2022)

Role of the mitral valve in left ventricular assist device pathophysiology
por: Noly, Pierre-Emmanuel, et al.
Publicado: (2022)

Transcatheter valvular therapies in patients with left ventricular assist devices
por: Dagher, Olina, et al.
Publicado: (2023)

Mechanical Assist Device-Assisted Percutaneous Coronary Intervention: The Use of Impella Versus Extracorporeal Membrane Oxygenation as an Emerging Frontier in Revascularization in Cardiogenic Shock
por: Vora, Neel, et al.
Publicado: (2023)

Is Neutrophil-to-Lymphocyte Ratio a Predictor of Coronary Artery Disease in Western Indians?
por: Sharma, Kamal, et al.
Publicado: (2017)

Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection
por: Melendo-Viu, María, et al.
Publicado: (2023)

Reciprocal interferences of the left ventricular assist device and the aortic valve competence
por: Vriz, Olga, et al.
Publicado: (2023)

Correction to: Sex Differences in Recovery and Device Replacement After Left Ventricular Assist Device Implantation as Destination Therapy
Publicado: (2022)

Immune Thrombocytopenia in Previously Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization): A Descriptive Research of 70 Instances With a Focus on Biomarkers, Predictive Outcomes, and Consequences
por: Sharma, Kamal, et al.
Publicado: (2022)

Physiologic Data-Driven Iterative Learning Control for Left Ventricular Assist Devices
por: Magkoutas, Konstantinos, et al.
Publicado: (2022)

Systemic thrombolysis in the management of pump thrombosis in patients with left ventricular assist devices
por: Kortekaas, Kirsten A., et al.
Publicado: (2022)

Commentary: Left ventricular assist device infection: Welcome to Babel!
por: Di Mauro, Michele, et al.
Publicado: (2021)

Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach
por: Samuels, Louis E, et al.
Publicado: (2012)

Dynamic Forecasts of Survival for Patients Living With Destination Left Ventricular Assist Devices: Insights From INTERMACS
por: Michelis, Katherine C., et al.
Publicado: (2020)

The role of atria in ventricular fibrillation after continuous-flow left ventricular assist device implantation in ovine model
por: Yu, Xin-Yi, et al.
Publicado: (2023)

Left ventricular assist device for end-stage heart failure: results of the first LVAD destination program in the Netherlands: Towards LVAD destination therapy in the Netherlands?
por: Manintveld, O. C.
Publicado: (2014)

Right heart failure after left ventricular assist device: From mechanisms to treatments
por: Bravo, Claudio A., et al.
Publicado: (2022)

Key questions about aortic insufficiency in patients with durable left ventricular assist devices
por: Calin, Eliza, et al.
Publicado: (2022)

Left ventricular assist devices promote changes in the expression levels of platelet microRNAs
por: Lombardi, Maria, et al.
Publicado: (2023)

Editorial: Multimodality imaging of left ventricular assist devices: applications in advanced heart failure
por: Pergola, Valeria, et al.
Publicado: (2023)

Ventricular Septal Rupture Management in Patients With Acute Myocardial Infarction: A Review
por: Tripathi, Apoorva, et al.
Publicado: (2023)

Prediction, prevention, and management of right ventricular failure after left ventricular assist device implantation: A comprehensive review
por: Rodenas-Alesina, Eduard, et al.
Publicado: (2022)

The Successful Implantation of Continuous-Flow Left Ventricular Assist Device as a Destination Therapy in Korea: Echocardiographic Assessment
por: Lee, Ga Yeon, et al.
Publicado: (2014)

Left ventricular assist device for end-stage heart failure: results of the first LVAD destination program in the Netherlands
por: Haeck, M. L. A., et al.
Publicado: (2014)

Stroke and pump thrombosis following left ventricular assist device implantation: The impact of the implantation technique
por: Nozdrzykowski, Michal, et al.
Publicado: (2023)

Cardiac mechanics and reverse remodelling under mechanical support from left ventricular assist devices
por: Pamias-Lopez, Blanca, et al.
Publicado: (2023)

Age and Sex Specific Reference Intervals for Modifiable Risk Factors of Cardiovascular Diseases for Gujarati Asian Indians
por: Sahoo, Sibasis, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q87gtjhpus2uq3r6g83r931p88